Design, Synthesis, and Biological Evaluation of 3,4-diarylmaleimides As Angiogenesis Inhibitors.
From: Department of Pharmacy, Johannes Gutenberg-University, Staudingerweg 5, D-55099 Mainz, Germany.
Journal of medicinal chemistry
- Publish Date: Feb 2006
- ISSN: 0022-2623
- Volume: 49
- Issue: 4
- Pages: 1271-81
- Medium: Print
- Language: English
- Citation (JAMA): Peifer Christian, Stoiber Thomas, Unger Eberhard, et al. Design, Synthesis, and Biological Evaluation of 3,4-diarylmaleimides As Angiogenesis Inhibitors.. J. Med. Chem. Feb 2006;49:1271-81
Abstract
The new analogue 2 of combretastatin A-4 was discovered to be an inhibitor of tubulin polymerization with an IC50 of 7.6 microM and reduced angiogenesis in the in vivo chick embryo model. Interestingly, in a series of 2,3-diarylmaleimides closely related to this lead, no other compound was found to be active in the tubulin polymerization assay. However, by screening in the in vivo chick embryo assay 10 was identified as a potent angiogenesis inhibitor indicating an alternative target. Indeed, molecular modeling studies suggest a reasonable binding mode of 10 at the ATP-binding site of the model kinase CDK2. Motivated by these results, analogues of 10 were screened for inhibitory activity in a panel of 12 selected protein kinases and a high affinity of 10 to VEGF-R2 was found showing an IC50 of 2.5 nM. Structure-activity relationships (SAR) for this compound series with the isolated enzyme and equivalent antiangiogenic activity in the chick embryo assay are presented herein.
Mesh Headings (Keywords): Adenosine Triphosphate, Angiogenesis Inhibitors, Animals, Binding Sites, Chick Embryo, Drug Design, Indoles, Maleimides, Models, Molecular, Pyrroles, Structure-Activity Relationship, Vascular Endothelial Growth Factor Receptor-2
Check for Full Text / PubMed Unique Identifier (PMID): 16480264
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.